Physician profile
Garni Barkhoudarian
NPI 1578707642
$52,635.08
in general payments reported to CMS, 2019-2025
29 companies · $16K in 2025
The $16K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $8,548 · 2021: $917 · 2022: $19K · 2023: $5,620 · 2024: $547 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Consulting Fee: $4,760 · Food and Beverage: $2,263 · Travel and Lodging: $702 · Debt Forgiveness: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,250.00 |
| Consulting Fee | $4,760.00 |
| Food and Beverage | $2,263.11 |
| Travel and Lodging | $702.37 |
| Debt Forgiveness | $323.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $17,275.45 | 2022-2025 | Progav 2.0 |
| Carl Zeiss Meditec USA, INC. | $15,059.52 | 2024-2025 | Convivo, Intrabeam 600 |
| Vascular Technology, INC. | $10,750.00 | 2020-2022 | |
| Medexus Pharma, INC. | $4,782.37 | 2022-2023 | Gleolan |
| Karl Storz Endoscopy-America | $1,243.69 | 2019-2025 | Hopkins |
| Zimmer Biomet Holdings, INC. | $566.84 | 2022-2025 | Neuro Plating System, Htr-Pekk, Neuro Plating System |
| Kls-Martin L.P. | $555.20 | 2022-2025 | Level One Neuro, Plate, Low Profile, Ladder, Neuro Screw, 2 X 2 Holes, 9 Mm, T=0.6 Mm, Cp Titanium, Qty: 001 Ea, Level One Neuro, Burr Hole Cover, Low Profile, Contoured, Neuro Screw, 5 Hole, 17 Mm Dia, T=0.3 Mm, Cp Titanium, Qty: 001 Ea, Level One Neuro, Plate, Low Profile, Str, Neuro Screw, 2 Hole, 15 Mm, T=0.6 Mm, Cp Titanium, Qty: 001 Ea |
| Stryker Corporation | $457.25 | 2019-2025 | Universal Neuro 3, N/A |
| Integra Lifesciences Corporation | $361.78 | 2019-2025 | Codman Certas, Codman Hakim, Cusa Clarity |
| Xoran Technologies LLC | $225.87 | 2021-2022 | |
| Omniscient Neurotechnology America Ltd | $185.65 | 2021-2023 | Quicktome |
| Monteris Medical Corporation | $170.64 | 2019-2025 | Neuroblate |
| Novocure INC. | $169.63 | 2024 | Optune |
| Boston Scientific Corporation | $147.61 | 2023 | |
| Merz Pharmaceuticals, LLC | $133.33 | 2023 | Xeomin |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $122.17 | 2025 | |
| Corcept Therapeutics | $121.57 | 2019 | |
| Chiasma, INC. | $61.99 | 2021 | |
| Qapel Medical INC | $46.19 | 2025 | |
| Siemens Medical Solutions USA, INC. | $39.29 | 2024 | Varian Ethos Treatment Planning |
| Ge Healthcare | $39.19 | 2019-2022 | |
| Baxter Healthcare | $23.98 | 2022 | |
| Depuy Synthes Sales INC. | $22.68 | 2025 | Trufill |
| Gt Medical Technologies, INC | $16.68 | 2019 | |
| Csl Behring | $16.10 | 2020 | |
| Longeviti Neuro Solutions INC | $14.24 | 2025 | Clearfit |
| Amryt Pharma Holdings Ltd | $14.17 | 2023 | Mycapssa |
| Lemaitre Vascular, INC. | $12.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garni Barkhoudarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.